Glioblastoma multiforme (GBM), a high-grade astrocytoma, is an incurable brain tumor
associated with genetic heterogeneity and dysregulated signaling pathways. As alternations …

The anti-tumor role and mechanisms of Cannabidiol (CBD), a non-psychotropic cannabinoid
compound, are not well studied especially in triple-negative breast cancer (TNBC). In the …

Background and Purpose The psychoactive cannabinoid Δ9‐tetrahydrocannabinol (THC)
and the non‐psychoactive cannabinoid cannabidiol (CBD) can both reduce cancer …

The aggressive behavior of Glioblastoma multiforme (GBM) is mainly due to high
invasiveness and proliferation rate as well as to high resistance to standard chemotherapy …

Approximately 80% of all malignant brain tumors are gliomas, which are primary brain
tumors. The most prevalent subtype of glioma, glioblastoma multiforme (GBM), is also the …

In recent years, evidence has accumulated that cannabinoids—especially the non-
psychoactive compound, cannabidiol (CBD)—possess promising medical and …

Several studies showed a potential anti-tumor role for cannabinoids, by modulating cell
signaling pathways involved in cancer cell proliferation, chemo-resistance and migration …

Cannabis and its major cannabinoid cannabidiol (CBD) are reported to exhibit anticancer
activity against skin tumors. However, the cytotoxic effects of other minor cannabinoids and …

It has been recently reported that cannabidiol (CBD), a non‐psychoactive cannabinoid, is
able to kill glioma cells, both in vivo and in vitro, independently of cannabinoid receptor …

The current treatment of glioblastoma is not sufficient, since they are heterogeneous and
often resistant to chemotherapy. Earlier studies demonstrated effects of specific cannabinoid …